Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-02-000652
Filing Date
2002-01-25
Accepted
2002-01-25 00:00:00
Documents
1
Period of Report
2002-03-13

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. y56740def14a.txt DEF 14A 143705
  Complete submission text file 0000950123-02-000652.txt   145289
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-15190 | Film No.: 02517429
SIC: 2835 In Vitro & In Vivo Diagnostic Substances